Patel Chem Specialities Limited announced its unaudited financial results for the half year ended September 30, 2026 (H1 FY27).

Financial Performance Highlights (₹ Lakhs)

  • Revenue from Operations: ₹7,649.10 in H1 FY27 vs ₹6,115.81 in H1 FY26, representing 25.07% YoY growth
  • EBITDA: ₹1,013.52 in H1 FY27 vs ₹888.07 in H1 FY26, representing 14.13% YoY growth
  • PAT: ₹626.90 in H1 FY27 vs ₹612.92 in H1 FY26, representing 2.28% YoY growth
  • Margin Analysis: EBITDA margins moderated by 127 basis points and PAT margins moderated by 183 basis points

Operational and Strategic Developments

  • Manufacturing Capacity Expansion: Successfully completed second expansion at Talod facility
  • Annual production capacity increased from 720 MT to 4,500 MT
  • Capital expenditure of approximately ₹20 crore funded through bank loans and internal accruals
  • Trial batches have commenced with commercial production expected to begin shortly
  • Expansion aims to support growing market demand and faster delivery schedules

Balance Sheet Position (as of September 30, 2026)

  • Shareholders' Funds: ₹105.77 crore compared to ₹99.50 crore as of March 31, 2026, representing 6.30% increase
  • Capital Work-in-Progress: ₹21.86 crore compared to ₹14.51 crore as of March 31, 2026, representing 50.66% increase
  • Cash and Bank Balances: ₹31.04 crore
  • Total Borrowings (long-term and short-term): ₹23.74 crore compared to ₹15.23 crore at FY26 end

Management Commentary

Mr. Bhupesh Patel, Managing Director, commented on the results:

  • Revenue growth of 25.07% reflects continued progress in pharmaceutical excipients and speciality chemicals business
  • Focus remains on improving operational efficiency and managing costs effectively despite margin moderation
  • Ongoing capital deployment reflected in increased capital work-in-progress
  • Forward focus on strengthening operational capabilities, maintaining financial discipline, improving working capital efficiency, and supporting sustainable long-term business growth

Company Overview

Patel Chem Specialities Limited operates in the specialty chemicals industry with focus on cellulose-based excipients and speciality chemicals used across:

  • Pharmaceutical applications
  • Food & beverage applications
  • Cosmetics applications
  • Industrial applications

The company maintains a diversified B2B customer base serving both domestic and international markets, with products used in regulated and quality-sensitive industries. Company holds certifications including US-DMF, GMP, and ISO 9001:2015.

Disclaimer Note

The document contains forward-looking statements subject to risks and uncertainties including government actions, local/political/economic developments, technological risks, and other factors that could cause actual results to differ materially from expectations.

Investor Relations Contact

ORIM CONNECT: +(91) 83693 82388 | letsconnect@orim.in | www.orim.in/orim-connect/